Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
  1. ホーム
  2. 癌の生存者における心臓血管バイオマーカーの利用の将来的展望: アメリカ心臓協会の科学的な声明
  1. ホーム
  2. 癌の生存者における心臓血管バイオマーカーの利用の将来的展望: アメリカ心臓協会の科学的な声明

関連する実験動画

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

癌の生存者における心臓血管バイオマーカーの利用の将来的展望: アメリカ心臓協会の科学的な声明

Vlad G Zaha, Salim S Hayek, Kevin M Alexander

    Circulation
    |November 10, 2021

    PubMed で要約を見る

    まとめ
    この要約は機械生成です。

    精密医療は 癌の生存率を向上させ 心血管の健康を 決定的に改善します この声明は,パーソナライズされた心臓腫瘍学のためのバイオマーカー,イメージングおよびデータの統合を調査し,がん治療中の心臓血管リスク評価とモニタリングにおける現在のギャップに対処します.

    キーワード:
    AHAの科学発表バイオマーカー癌の生存者心臓病科腫瘍学精密医療

    さらに関連する動画

    Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
    10:03

    Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

    Published on: January 28, 2020

    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
    07:25

    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

    Published on: September 22, 2020

    関連する実験動画

    Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
    14:24

    Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

    Published on: January 21, 2018

    Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
    10:03

    Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

    Published on: January 28, 2020

    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
    07:25

    Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

    Published on: September 22, 2020

    科学分野:

    • 心臓腫瘍学
    • バイオマーカーの発見
    • 精密医療

    背景:

    • 精密医療と免疫療法によって 癌の生存率が向上しています
    • 心血管の健康は 今や がん患者の全般的な健康状態の 決定的な要因となっています
    • 伝統的な組織診断は癌の治療に不可欠ですが,心臓腫瘍学では限られています.

    研究 の 目的:

    • 心臓腫瘍学における心血管組織診断の全身的なアプローチを探求する.
    • 心臓腫瘍学の様々な臨床シナリオに このアプローチをパーソナライズする
    • 現在の心血管バイオマーカーの応用における限界と知識のギャップを解決する.

    主な方法:

    • 癌患者の心血管バイオマーカーに関する文献レビュー
    • 循環するバイオマーカー,マルチモダリティーイメージング,パノミクス,デジタル生理学的データを統合する探索.
    • 心臓腫瘍学におけるバイオマーカー概念の広範な定義

    主要な成果:

    • リスクの階層化,モニタリング,損傷の検出のための心血管バイオマーカーの使用における制限と知識のギャップを特定した.
    • 癌の交差点における心臓血管バイオマーカーに関する現在の文献を要約した.
  • 心臓腫瘍学における体系的,個別的なアプローチの必要性を強調した.
  • 結論:

    • 心臓がん診断の課題を克服するために,多様なデータストリームを統合したシステムアプローチが提案されています.
    • このアプローチのパーソナライゼーションは 多様な患者集団や癌の種類や治療法にとって 鍵となるものです
    • バイオマーカーの発見,検証,臨床応用における 協調的な努力は,心臓腫瘍学ネクサスで必要である.